Impact of Trends and Gender Disparity in Obesity on Future Type 2 Diabetes in Turkey: a Mathematical Modelling Analysis

Overview

Journal BMJ Open

Specialty General Medicine

Date 2022 May 11

PMID 35545390

Authors

Gul Anil Anakok

Susanne F Awad

Cigdem Caglayan

Peijue Huangfu

Laith J Abu-Raddad

Belgin Unal

Julia Alison Critchley

Affiliations

Soon will be listed here.

Abstract

Background: Using a previously developed and validated mathematical model, we predicted future prevalence of type 2 diabetes mellitus (T2DM) and major modifiable risk factors (obesity, physical inactivity and smoking) stratified by age and sex in Turkey up to the year 2050.

Methods: Our deterministic compartmental model fitted nationally representative demographic and risk factor data simultaneously for Turkish adults (aged 20-79) between 1997 and 2017, then estimated future trends. Our novel approach explored the impact of future obesity trends on these projections, specifically modelling (1) a gradual fall in obesity in women after the year 2020 until it equalled the age-specific levels seen in men and (2) cessation of the rise in obesity after 2020.

Results: T2DM prevalence is projected to rise from an estimated 14.0% (95% uncertainty interval (UI) 12.8% to 16.0%) in 2020 to 18.4% (95% UI 16.9% to 20.9%) by 2050; 19.7% in women and 17.2% in men by 2050; reflecting high levels of obesity (39.7% for women and 22.0% for men in 2050). Overall, T2DM prevalence could be reduced by about 4% if obesity stopped rising after 2020 or by 12% (22% in women) if obesity prevalence among women could be lowered to equal that of men. The higher age-specific obesity prevalence among women resulted in 2 076 040 additional women developing T2DM by the year 2050.

Conclusion: T2DM is common in Turkey and will remain so. Interventions and policies targeting the high burden of obesity (and low physical activity levels), particularly in women, could significantly impact future disease burdens.

Citing Articles

Unraveling the Causal Relationship Between Non-Communicable Diseases, Obesity, and Health Expenditure: Insights from the Toda-Yamamoto Approach.

Yilmaz S, Boz C, Eren F, Gunal A Healthcare (Basel). 2025; 13(1.

PMID: 39791608 PMC: 11720058. DOI: 10.3390/healthcare13010001.

Nonlinear association between the triglyceride-glucose index and diabetes mellitus in overweight and obese individuals: a cross-sectional retrospective analysis.

Sun Y, Gu Y, Zhou Y, Liu A, Lin X, Wang X Diabetol Metab Syndr. 2024; 16(1):193.

PMID: 39118153 PMC: 11308203. DOI: 10.1186/s13098-024-01434-5.

Epidemiological impact of public health interventions against diabetes in Qatar: mathematical modeling analyses.

Alareeki A, Awad S, Critchley J, El-Nahas K, Al-Hamaq A, Alyafei S Front Public Health. 2023; 11:1167807.

PMID: 37404285 PMC: 10315912. DOI: 10.3389/fpubh.2023.1167807.

'No one ever asks about something that actually is relevant to my life': A qualitative study of diabetes and diabetes care experiences of young women with type 2 diabetes during their reproductive years.

Celik A, Sturt J, Temple A, Forbes A, Forde R Diabet Med. 2022; 40(3):e15017.

PMID: 36448267 PMC: 10107676. DOI: 10.1111/dme.15017.

References

Colchero M, Rivera-Dommarco J, Popkin B, Ng S . In Mexico, Evidence Of Sustained Consumer Response Two Years After Implementing A Sugar-Sweetened Beverage Tax. Health Aff (Millwood). 2017; 36(3):564-571. PMC: 5442881. DOI: 10.1377/hlthaff.2016.1231. View

Neuenschwander M, Ballon A, Weber K, Norat T, Aune D, Schwingshackl L . Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. BMJ. 2019; 366:l2368. PMC: 6607211. DOI: 10.1136/bmj.l2368. View

Kanter R, Caballero B . Global gender disparities in obesity: a review. Adv Nutr. 2012; 3(4):491-8. PMC: 3649717. DOI: 10.3945/an.112.002063. View

Lean M, Leslie W, Barnes A, Brosnahan N, Thom G, McCombie L . Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2017; 391(10120):541-551. DOI: 10.1016/S0140-6736(17)33102-1. View

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe. Diabetologia. 1999; 42(6):647-54. DOI: 10.1007/s001250051211. View

Awad S, Al-Mawali A, Al-Lawati J, Morsi M, Critchley J, Abu-Raddad L . Forecasting the type 2 diabetes mellitus epidemic and the role of key risk factors in Oman up to 2050: Mathematical modeling analyses. J Diabetes Investig. 2020; 12(7):1162-1174. PMC: 8264408. DOI: 10.1111/jdi.13452. View

Smed S, Scarborough P, Rayner M, Jensen J . The effects of the Danish saturated fat tax on food and nutrient intake and modelled health outcomes: an econometric and comparative risk assessment evaluation. Eur J Clin Nutr. 2016; 70(6):681-6. DOI: 10.1038/ejcn.2016.6. View

Islek D, Demiral Y, Ergor G, Unal B . Quantifying gender inequalities in obesity: findings from the Turkish population-based Balcova Heart Study. Public Health. 2020; 186:265-270. DOI: 10.1016/j.puhe.2020.06.044. View

10.

Unal B, Sozmen K, Arik H, Gerceklioglu G, Altun D, Simsek H . Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008. BMC Public Health. 2013; 13:1135. PMC: 4234124. DOI: 10.1186/1471-2458-13-1135. View

11.

Awad S, Oflaherty M, El-Nahas K, Al-Hamaq A, Critchley J, Abu-Raddad L . Preventing type 2 diabetes mellitus in Qatar by reducing obesity, smoking, and physical inactivity: mathematical modeling analyses. Popul Health Metr. 2020; 17(1):20. PMC: 6937668. DOI: 10.1186/s12963-019-0200-1. View

12.

Garawi F, DEVRIES K, Thorogood N, Uauy R . Global differences between women and men in the prevalence of obesity: is there an association with gender inequality?. Eur J Clin Nutr. 2014; 68(10):1101-6. DOI: 10.1038/ejcn.2014.86. View

13.

Sozmen K, Unal B, Capewell S, Critchley J, Oflaherty M . Estimating diabetes prevalence in Turkey in 2025 with and without possible interventions to reduce obesity and smoking prevalence, using a modelling approach. Int J Public Health. 2014; 60 Suppl 1:S13-21. DOI: 10.1007/s00038-014-0622-2. View

14.

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

15.

Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S . Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care. 2002; 25(9):1551-6. DOI: 10.2337/diacare.25.9.1551. View

16.

Epping-Jordan J, Galea G, Tukuitonga C, Beaglehole R . Preventing chronic diseases: taking stepwise action. Lancet. 2005; 366(9497):1667-71. DOI: 10.1016/S0140-6736(05)67342-4. View

17.

Awad S, Huangfu P, Dargham S, Ajlouni K, Batieha A, Khader Y . Characterizing the type 2 diabetes mellitus epidemic in Jordan up to 2050. Sci Rep. 2020; 10(1):21001. PMC: 7713435. DOI: 10.1038/s41598-020-77970-7. View

18.

Pan A, Sun Q, Bernstein A, Schulze M, Manson J, Willett W . Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. Am J Clin Nutr. 2011; 94(4):1088-96. PMC: 3173026. DOI: 10.3945/ajcn.111.018978. View

19.

Awad S, Oflaherty M, Critchley J, Abu-Raddad L . Forecasting the burden of type 2 diabetes mellitus in Qatar to 2050: A novel modeling approach. Diabetes Res Clin Pract. 2017; 137:100-108. DOI: 10.1016/j.diabres.2017.11.015. View

20.

Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N . Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013; 28(2):169-80. PMC: 3604592. DOI: 10.1007/s10654-013-9771-5. View